Keiichi Yamamoto
Overview
Explore the profile of Keiichi Yamamoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
97
Citations
913
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yamamura R, Nagayoshi Y, Nishiguchi K, Kaneko H, Yamamoto K, Matsushita K, et al.
mBio
. 2024 Dec;
16(1):e0312424.
PMID: 39660929
Importance: This study reveals the differences in the fate and release of modified nucleosides in bacteria and mammals. Additionally, our study highlights that external bacteria-damaging factors, such as antibiotics and...
2.
Hayashi Y, Odagiri K, Ishii Y, Yamamoto K, Takahashi T, Yamashita K, et al.
Minim Invasive Ther Allied Technol
. 2024 Nov;
:1-8.
PMID: 39499249
Background: Magnesium alloys have great potentials as bioabsorbable implants, whereas the difficulty in evaluating hydrogen gas produced in the degradation process has hindered their research and development. In this study,...
3.
Oda K, Hayashi H, Yamamoto K, Kondo S, Katanoda T, Okamoto S, et al.
Infect Control Hosp Epidemiol
. 2024 Oct;
:1-9.
PMID: 39387201
Objective: Days of antibiotic spectrum coverage (days of ASC: DASC) is a metric for antibiotic usage calculated by ASC scores for spectrum and addresses limitations of days of therapy (DOT),...
4.
Akiya I, Ishihara T, Yamamoto K
JMIR Med Inform
. 2024 Jun;
12:e55118.
PMID: 38889082
Background: Synthetic patient data (SPD) generation for survival analysis in oncology trials holds significant potential for accelerating clinical development. Various machine learning methods, including classification and regression trees (CART), random...
5.
Yamamoto K, Sakaguchi M, Onishi A, Yokoyama S, Matsui Y, Yamamoto W, et al.
PLoS One
. 2024 May;
19(5):e0302308.
PMID: 38709812
Rheumatoid arthritis causes joint inflammation due to immune abnormalities, resulting in joint pain and swelling. In recent years, there have been considerable advancements in the treatment of this disease. However,...
6.
Matsuzaki K, Kitayama M, Yamamoto K, Aida R, Imai T, Ishida M, et al.
JMIR Med Inform
. 2023 Dec;
11:e46725.
PMID: 38153801
Background: In recent years, many researchers have focused on the use of legacy data, such as pooled analyses that collect and reanalyze data from multiple studies. However, the methodology for...
7.
Saito S, Suzuki K, Ohtani R, Maki T, Kowa H, Tachibana H, et al.
JAMA Netw Open
. 2023 Dec;
6(12):e2344938.
PMID: 38048134
Importance: Recent evidence indicates the efficacy of β-amyloid immunotherapy for the treatment of Alzheimer disease, highlighting the need to promote β-amyloid removal from the brain. Cilostazol, a selective type 3...
8.
Yoshinouchi T, Yamamoto K, Migita M, Yokoyama T, Nakamura T, Matsuoka M
Med Mycol Case Rep
. 2023 Nov;
42:100617.
PMID: 38022890
We report a patient with anorexia nervosa without bronchiectasis and cystic fibrosis who developed acute pneumonia caused by (). The black fungus found in multiple sputum cultures was determined to...
9.
Toyomoto T, Ono K, Shiba T, Momitani K, Zhang T, Tsutsuki H, et al.
Front Microbiol
. 2023 Nov;
14:1276447.
PMID: 37965540
A principal concept in developing antibacterial agents with selective toxicity is blocking metabolic pathways that are critical for bacterial growth but that mammalian cells lack. Serine -acetyltransferase (CysE) is an...
10.
Maekawa N, Konnai S, Hosoya K, Kim S, Kinoshita R, Deguchi T, et al.
PLoS One
. 2023 Oct;
18(10):e0291727.
PMID: 37792729
Immune checkpoint inhibitors (ICIs) have been developed for canine tumour treatment, and pilot clinical studies have demonstrated their antitumour efficacy in dogs with oral malignant melanoma (OMM). Although ICIs have...